Poseida Therapeutics Raises $110 Million in Series D Financing

SAN DIEGO, June 25, 2020 -- (Healthcare Sales & Marketing Network) -- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene ... Biopharmaceuticals, Oncology, Venture Capital Poseida Therapeutics, piggyBac, Cas-CLOVER, gene engineering
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news